A study to compare the efficacy and adverse effects of metformin versus myoinositol plus d-chiroinositol combination therapy in polycystic ovarian syndrome
Phase 4
Completed
- Conditions
- Health Condition 1: E282- Polycystic ovarian syndrome
- Registration Number
- CTRI/2019/03/018306
- Lead Sponsor
- Dr Sukhmani Jaura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
Women fulfilling 2 out of 3 criteria of Rotterdam criteria
Oligo menorrhea and/or Anovulation
Clinical and/or hormonal parameters of hyperandrogenism that may be associated with Hirsutism
Polycystic ovaries in ultrasound findings
Exclusion Criteria
Women with pre-existing endocrine disorder
History of Hypertension & Diabetes Mellitus
Women who received previous treatment with other drugs within last 6 months
Pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method